These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29132354)

  • 1. Correction to: Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin.
    Hayashi T; Fukui T; Nakanishi N; Yamamoto S; Tomoyasu M; Osamura A; Ohara M; Yamamoto T; Ito Y; Hirano T
    Cardiovasc Diabetol; 2017 Nov; 16(1):149. PubMed ID: 29132354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
    Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
    Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of small dense low-density lipoprotein and adiponectin with complications of type 2 diabetes.
    Esteghamati A; Asnafi S; Eslamian M; Noshad S; Nakhjavani M
    Endocr Res; 2015; 40(1):14-9. PubMed ID: 24832870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher levels of small dense low-density lipoprotein (LDL) are associated with cardiac autonomic neuropathy in patients with type 2 diabetes.
    Jang EH; Park YM; Hur J; Kim MK; Ko SH; Baek KH; Song KH; Lee KW; Kwon HS
    Diabet Med; 2013 Jun; 30(6):694-701. PubMed ID: 23506430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.
    Temelkova-Kurktschiev T; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):75-9. PubMed ID: 15031770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of small dense low-density lipoprotein in coronary artery disease patients with normal plasma cholesterol levels].
    Koba S; Hirano T; Sakaue T; Sakai K; Kondo T; Yorozuya M; Suzuki H; Murakami M; Katagiri T
    J Cardiol; 2000 Dec; 36(6):371-8. PubMed ID: 11190580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of dipeptidyl peptidase-4 inhibitors on serum adiponectin: a meta-analysis.
    Liu X; Men P; Wang Y; Zhai S; Liu G
    Lipids Health Dis; 2016 Nov; 15(1):204. PubMed ID: 27881129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The small dense LDL particle/large buoyant LDL particle ratio is associated with glucose metabolic status in pregnancy.
    Chen Y; Du M; Xu J; Chen D
    Lipids Health Dis; 2017 Dec; 16(1):244. PubMed ID: 29241449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of action.
    Winkler K; Abletshauser C; Hoffmann MM; Friedrich I; Baumstark MW; Wieland H; März W
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5485-90. PubMed ID: 12466341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
    Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
    Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions.
    Homma K; Homma Y; Ozawa H; Shiina Y; Shibata T; Yoshida T; Hasegawa K; Kanda T; Tokuyama H; Wakino S; Hayashi K; Itoh H; Hori S
    J Clin Lipidol; 2015; 9(6):751-757. PubMed ID: 26687695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fenofibrate and ezetimibe, both as monotherapy and in coadministration, on cholesterol mass within lipoprotein subfractions and low-density lipoprotein peak particle size in patients with mixed hyperlipidemia.
    Tribble DL; Farnier M; Macdonell G; Perevozskaya I; Davies MJ; Gumbiner B; Musliner TA
    Metabolism; 2008 Jun; 57(6):796-801. PubMed ID: 18502262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects.
    Geiss HC; Otto C; Schwandt P; Parhofer KG
    Metabolism; 2001 Aug; 50(8):983-8. PubMed ID: 11474489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.
    Kinoshita C; Nagano T; Seki N; Tomita Y; Sugita T; Aida Y; Itagaki M; Satoh K; Sutoh S; Abe H; Tsubota A; Aizawa Y
    World J Gastroenterol; 2016 Aug; 22(29):6716-25. PubMed ID: 27547014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small-dense LDL cholesterol/large-buoyant LDL cholesterol ratio as an excellent marker for indicating lipodystrophy in HIV-infected patients.
    Srisawasdi P; Suwalak T; Sukasem C; Chittamma A; Pocathikorn A; Vanavanan S; Puangpetch A; Santon S; Chantratita W; Kiertiburanakul S; Kroll MH
    Am J Clin Pathol; 2013 Oct; 140(4):506-15. PubMed ID: 24045547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein.
    Sattar N; Greer IA; Louden J; Lindsay G; McConnell M; Shepherd J; Packard CJ
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2483-91. PubMed ID: 9253322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.